Last updated: 16 February 2024 at 5:05pm EST

Neil Almstead Net Worth




The estimated Net Worth of Neil Gregory Almstead is at least $8.54 Million dollars as of 30 January 2024. Neil Almstead owns over 646 units of PTC Therapeutics Inc stock worth over $119,593 and over the last 11 years he sold PTCT stock worth over $5,903,762. In addition, he makes $2,518,770 as Chief Technical Operations Officer at PTC Therapeutics Inc.

Neil Almstead PTCT stock SEC Form 4 insiders trading

Neil has made over 32 trades of the PTC Therapeutics Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he sold 646 units of PTCT stock worth $17,604 on 30 January 2024.

The largest trade he's ever made was exercising 104,038 units of PTC Therapeutics Inc stock on 4 January 2021 worth over $2,156,708. On average, Neil trades about 7,237 units every 88 days since 2014. As of 30 January 2024 he still owns at least 3,706 units of PTC Therapeutics Inc stock.

You can see the complete history of Neil Almstead stock trades at the bottom of the page.





Neil Almstead biography

Dr. Neil Almstead Ph.D. serves as Chief Technical Operations Officer of the Company. Dr. Almstead has been employed with PTC since 2000. He served as our Executive Vice President, Research, Pharmaceutical Operations and Technology from January 2015 to December 2018, Senior Vice President, Research and CMC from July 2008 to December 2014 and Senior Vice President, Chemistry and CMC from January 2007 to June 2008. Prior to joining PTC, Dr. Almstead served as Project Manager at Procter & Gamble Company, a publicly traded consumer products company. Dr. Almstead has co-authored more than 75 publications and patents pertaining to the design and synthesis of lead candidate compounds for genetic disorders, oncology and inflammatory diseases. Dr. Almstead received a B.S. from Clarkson University and a Ph.D. in Organic Chemistry from the University of Illinois at Urbana-Champaign.

What is the salary of Neil Almstead?

As the Chief Technical Operations Officer of PTC Therapeutics Inc, the total compensation of Neil Almstead at PTC Therapeutics Inc is $2,518,770. There are 1 executives at PTC Therapeutics Inc getting paid more, with Stuart Peltz having the highest compensation of $7,759,440.



How old is Neil Almstead?

Neil Almstead is 53, he's been the Chief Technical Operations Officer of PTC Therapeutics Inc since 2018. There are 15 older and 4 younger executives at PTC Therapeutics Inc. The oldest executive at PTC Therapeutics Inc is Dr. Allan Steven Jacobson, 75, who is the Independent Co-Founder, Chairman of Scientific Advisory Board & Director.

What's Neil Almstead's mailing address?

Neil's mailing address filed with the SEC is C/O PTC THERAPEUTICS, INC., 100 CORPORATE COURT, SOUTH PLAINFIELD, NJ, 07080.

Insiders trading at PTC Therapeutics Inc

Over the last 12 years, insiders at PTC Therapeutics Inc have traded over $50,602,930 worth of PTC Therapeutics Inc stock and bought 3,730,934 units worth $57,374,337 . The most active insiders traders include Suisse/ Credit, Adam Koppel und Bioventures Cayman Ltd Hbm. On average, PTC Therapeutics Inc executives and independent directors trade stock every 16 days with the average trade being worth of $888,748. The most recent stock trade was executed by Pierre Gravier on 16 July 2024, trading 2,269 units of PTCT stock currently worth $77,191.



What does PTC Therapeutics Inc do?

ptc is biopharmaceutical company focused on the discovery and development of orally-administered, proprietary small molecule drugs that target post-transcriptional control processes. while ptc’s discovery programs are directed at targets in multiple therapeutic areas, ptc is focusing particularly on the development and commercialization of treatments for orphan and ultra-orphan disorders. post-transcriptional control processes regulate the rate and timing of protein production and are essential to proper cellular function. ptc’s internally-discovered pipeline addresses multiple therapeutic areas, including neuromuscular disorders, oncology and infectious diseases. for more information on the company, please visit our website www.ptcbio.com.



What does PTC Therapeutics Inc's logo look like?

PTC Therapeutics Inc logo

Complete history of Neil Almstead stock trades at PTC Therapeutics Inc

Datum
#
Unternehmen
Insider
Trans.
Transaktion
Anzahl der Aktien Preis je Aktie Gesamtpreis Anzahl der Aktien nach Quelle
30 Jan 2024 Neil Gregory Almstead
CHIEF TECHNICAL OPS OFFICER
Verkauf 646 $27.25 $17,604
30 Jan 2024
3,706
8 Jan 2024 Neil Gregory Almstead
CHIEF TECHNICAL OPS OFFICER
Verkauf 2,910 $28.85 $83,954
8 Jan 2024
3,734
31 Jan 2023 Neil Gregory Almstead
CHIEF TECHNICAL OPS OFFICER
Verkauf 658 $45.63 $30,025
31 Jan 2023
3,259
24 Jan 2023 Neil Gregory Almstead
CHIEF TECHNICAL OPS OFFICER
Verkauf 44 $47.45 $2,088
24 Jan 2023
3,287
10 Jan 2023 Neil Gregory Almstead
CHIEF TECHNICAL OPS OFFICER
Verkauf 910 $43.58 $39,658
10 Jan 2023
3,331
9 Jan 2023 Neil Gregory Almstead
CHIEF TECHNICAL OPS OFFICER
Verkauf 759 $41.66 $31,620
9 Jan 2023
3,385
1 Feb 2022 Neil Gregory Almstead
CHIEF TECHNICAL OPS OFFICER
Verkauf 632 $40.00 $25,280
1 Feb 2022
2,420
25 Jan 2022 Neil Gregory Almstead
CHIEF TECHNICAL OPS OFFICER
Verkauf 43 $39.31 $1,690
25 Jan 2022
2,447
7 Jan 2022 Neil Gregory Almstead
CHIEF TECHNICAL OPS OFFICER
Verkauf 801 $38.53 $30,863
7 Jan 2022
1,710
4 Jan 2022 Neil Gregory Almstead
CHIEF TECHNICAL OPS OFFICER
Verkauf 64 $41.16 $2,634
4 Jan 2022
1,755
1 Feb 2021 Neil Gregory Almstead
CHIEF TECHNICAL OPS OFFICER
Verkauf 1,001 $56.96 $57,017
1 Feb 2021
1,819
25 Jan 2021 Neil Gregory Almstead
CHIEF TECHNICAL OPS OFFICER
Verkauf 541 $63.15 $34,164
25 Jan 2021
1,847
8 Jan 2021 Neil Gregory Almstead
CHIEF TECHNICAL OPS OFFICER
Optionausübung 1,300 $27.05 $35,165
8 Jan 2021
3,688
5 Jan 2021 Neil Gregory Almstead
CHIEF TECHNICAL OPS OFFICER
Verkauf 626 $62.37 $39,044
5 Jan 2021
1,788
4 Jan 2021 Neil Gregory Almstead
CHIEF TECHNICAL OPS OFFICER
Optionausübung 104,038 $20.73 $2,156,708
4 Jan 2021
2,512
4 Nov 2020 Neil Gregory Almstead
CHIEF TECHNICAL OPS OFFICER
Optionausübung 24,062 $11.23 $270,216
4 Nov 2020
48,964
5 Feb 2020 Neil Gregory Almstead
CHIEF TECHNICAL OPS OFFICER
Verkauf 54,445 $55.00 $2,994,475
5 Feb 2020
1,912
23 Jan 2020 Neil Gregory Almstead
CHIEF TECHNICAL OPS OFFICER
Verkauf 46 $53.25 $2,450
23 Jan 2020
5,987
6 Jan 2020 Neil Gregory Almstead
CHIEF TECHNICAL OPS OFFICER
Verkauf 693 $48.29 $33,465
6 Jan 2020
6,033
7 Jan 2019 Neil Gregory Almstead
CHIEF TECHNICAL OPS OFFICER
Verkauf 653 $34.75 $22,692
7 Jan 2019
5,649
19 Jun 2018 Neil Gregory Almstead
CHIEF TECHNICAL OPS OFFICER
Optionausübung 20,000 $10.85 $217,000
19 Jun 2018
37,154
5 Jan 2018 Neil Gregory Almstead
CHIEF TECHNICAL OPS OFFICER
Verkauf 703 $18.03 $12,675
5 Jan 2018
5,125
3 Jan 2018 Neil Gregory Almstead
CHIEF TECHNICAL OPS OFFICER
Verkauf 77 $17.67 $1,361
3 Jan 2018
5,207
5 Jan 2017 Neil Gregory Almstead
CHIEF TECHNICAL OPS OFFICER
Verkauf 78 $11.82 $922
5 Jan 2017
2,687
27 Sep 2016 Neil Gregory Almstead
CHIEF TECHNICAL OPS OFFICER
Optionausübung 10,000 $10.85 $108,500
27 Sep 2016
10,000
15 Apr 2015 Neil Gregory Almstead
CHIEF TECHNICAL OPS OFFICER
Verkauf 9,511 $68.65 $652,930
15 Apr 2015
0
19 Mar 2015 Neil Gregory Almstead
CHIEF TECHNICAL OPS OFFICER
Verkauf 20,370 $70.02 $1,426,307
19 Mar 2015
9,511
10 Mar 2015 Neil Gregory Almstead
CHIEF TECHNICAL OPS OFFICER
Verkauf 79 $70.71 $5,586
10 Mar 2015
1,295
17 Feb 2015 Neil Gregory Almstead
CHIEF TECHNICAL OPS OFFICER
Optionausübung 3,904 $10.85 $42,358
17 Feb 2015
33,785
20 Jan 2015 Neil Gregory Almstead
CHIEF TECHNICAL OPS OFFICER
Optionausübung 26,096 $10.85 $283,142
20 Jan 2015
30,877
4 Dec 2014 Neil Gregory Almstead
CHIEF TECHNICAL OPS OFFICER
Verkauf 175 $50.00 $8,750
4 Dec 2014
1,374
19 Mar 2014 Neil Gregory Almstead
CHIEF TECHNICAL OPS OFFICER
Verkauf 10,859 $31.91 $346,511
19 Mar 2014
29,881


PTC Therapeutics Inc executives and stock owners

PTC Therapeutics Inc executives and other stock owners filed with the SEC include: